Luminis Health Doctors Community Medical Center, Inc.

Luminis Health Doctors Community Medical Center, Inc., operating as Doctors Community Hospital, is a non-profit healthcare institution registered to receive federal contract and grant awards. As a tax-exempt corporate entity, it plays a crucial role in providing community-focused healthcare services. The organization has been registered in SAM.gov since December 17, 2011, with its current registration valid until February 14, 2025. Doctors Community Hospital offers specialized services to the federal government, primarily in the areas of data collection related to consumer product injuries and participation in public health initiatives. Its status as both a federal contract awardee and grant sub-awardee underscores its multifaceted contributions to public health and safety.

In terms of federal contracts, Luminis Health Doctors Community Medical Center has recently been awarded a significant contract by the Consumer Product Safety Commission (CPSC). This $28,909.81 firm fixed-price purchase order contract, awarded on July 1, 2024, and set to run until June 30, 2029, tasks the hospital with collecting data on consumer product-related injuries. The contract was awarded on a sole-source basis under FAR 6.302-1, without any set-aside designation. This work highlights the hospital's capability to provide valuable statistical data for analysis purposes, contributing to consumer safety efforts. The CPSC's decision to award this contract to Doctors Community Hospital emphasizes the institution's unique position as a randomly selected hospital capable of fulfilling this specific data collection requirement, which will be used to inform consumer product safety analyses and initiatives.

Regarding federal grant sub-awards, Luminis Health Doctors Community Medical Center has been involved in several important public health initiatives. The hospital participates in the Maryland Breast and Cervical Cancer Early Detection Program (MBCCEDP), working to recruit and enroll eligible women for breast and cervical cancer screening, diagnostic testing, nursing case management services, and patient navigation. This sub-award, managed through the Maryland Department of Health, aligns with the requirements and standards established by the CDC and its National Breast and Cervical Cancer Early Detection Program. Additionally, the hospital received two sub-awards through the Maryland Department of Emergency Management, likely in response to the COVID-19 pandemic. One sub-award, covering January 2020 to June 2022, was designated for space conversions, while another, spanning March 2020 through June 2022, was allocated for Personal Protective Equipment (PPE) expenses. These sub-awards demonstrate the hospital's crucial role in emergency response efforts, adapting its facilities and ensuring proper safety measures during a critical period.